Navigation Links
Fertility Treatment And Its Concerns

One third of the people who are undergoing fertility treatment do not confide in their employers about the treatment because they are apprehensive // about the repercussions .In a survey carried out by the Infertility Network of the UK on approximately 300 patients, it was observed that the patients were worried about not being able to gain the sympathy of their bosses. The survey, done for National Infertility Day, revealed that although the majority of people confide in their employers , 29% felt they could not discuss the subject with them.

The other reasons for not telling employers include worries about colleagues finding out, and a feeling that their infertility problem was a very private matter. One in seven couples in the UK experience fertility problems.

Although the time taken for treatment varied for different individuals ,the majority had taken less than ten working days.

Some employers acknowledge that infertility is a medical condition, and allow their staff to take time off for treatment. A leaflet on fertility information has been produced to educate and encourage employers to be more supportive to an an employee who is going through fertility treatment and how support from the employer can ease the stress of the patient making it more effective.


'"/>




Page: 1

Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Restoration Of Fertility After Cancer Treatment
3. Mobile Phones Found To Reduce A Man’s Fertility by 30
4. High-Protein Diet Found To Reduce Fertility
5. Suppressing A Girls Height In Adolescence Could Lead to Fertility Problems
6. Improving Fertility In Patients With Cervical Cancer
7. Late Pregnancy Women Face The Risk Of Heartbreak, Fertility Problems
8. Fertility Treatment Offered During Summer Has Better Chances For Success
9. Detrimental Effect Of Chronic Alcoholism On Male Fertility
10. Fertility increased in Thirties
11. New Home-Fertility Kit Launched For Men
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology: